CARE revises ratings assigned to Orchid Pharma’s bank facilities

18 Apr 2017 Evaluate

Credit rating agency, Credit Analysis & Research (CARE) has revised rating assigned to Orchid Pharma’s long term bank facilities worth Rs 2687.49 crore to ‘D’ from ‘B-’. The rating agency has also revised rating assigned to company’s short term bank facilities worth Rs 498.50 crore to ‘D’ from ‘A4’. The revision in ratings assigned to the bank facilities of Orchid Pharma takes into account instances of delays in debt servicing.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

761.60 -9.00 (-1.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×